Toggle menu

HU-FIX Trial

Start date:
2018
End date:
2020
Co-ordinated by:
Clare Moceivei
Main trial site:
Royal Infirmary of Edinburgh

Assisting in identifying patients with Humeral shaft fractures in the ED by screening.

 

Giving patient information sheets to introduce the study, so patient has had adequate time to read and make decision about going into the trial before going to the fracture clinic.

 

Research Team

Rachel O'Brien

Lead Research Nurse

Julia Grahamslaw

Lead Research Nurse

Polly Black

Senior Research Nurse

Sian Dalgleish

Senior Research Nurse

Alison Williams

Senior Research Nurse

Fiona McCurrach

Senior Research Nurse

Caroline Blackstock

AMU Senior Research Nurse

More EMERGE Trials

The purpose of this study is to test a new vaccine, ChAdOx1 nCoV-19, against COVID-19 in healthy volunteers.

The ChAdOx1 nCoV-19 vaccine has been developed in Oxford in an effort to protect healthy people from the pandemic. This study will evaluate the safety of the vaccine and its ability to generate an immune response against the virus.  

This is a randomised trial. Participants will be randomly allocated to receive either the ChAdOx1 nCoV-19 vaccine, or a Men ACWY (meningitus vaccine). Volunteers will not be told which vaccine they will receive.

Participants will be asked to return for 6 visits across 12 months to evaluate their health.

Across the UK the trial aims to recruit 10,260 volunteers.

If you are interested in taking part, please click on this link and complete the online questionnaire: https://www.covid19vaccinetrial.co.uk/participate-edinburgh

Read more

COV_002 Vaccine Trial

The purpose of this study is to test a new vaccine against COVID-19 in healthy volunteers.